| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 2 | |
| #2 | United States | 2 | |
| #3 | Australia | 1 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | Germany | 1 | |
| #7 | EAPO (Eurasian Patent Organization) | 1 | |
| #8 | Iceland | 1 | |
| #9 | Republic of Korea | 1 | |
| #10 | Mexico | 1 | |
| #11 | Norway | 1 | |
| #12 | New Zealand | 1 | |
| #13 | Poland | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Haller Hermann | 12 |
| #2 | Menne Jan | 12 |
| #3 | Hermann Haller | 2 |
| #4 | Gueler Sinan | 1 |
| #5 | Jan Menne | 1 |
| Publication | Filing date | Title |
|---|---|---|
| DE102004019413A1 | Use of substances (e.g. nucleic acids, proteins and peptides), which restrain/reduce the expression and/or activity of protein kinase C-epsilon for the treatment/prevention of e.g. circulatory and vascular diseases | |
| CN1684694A | Inhibition of protein kinase C alpha for treatment of diabetes mellitus and cardiovascular diseases |